Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Bauernfeind

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nature Methods|January 8, 2013
iGLuc: a luciferase-based inflammasome and protease activity reporterEva Bartok, Franz Bauernfeind, Maria G Khaminets, et al.
Nature|January 23, 2009
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCVeit Hornung, Andrea Ablasser, Marie Charrel-Dennis, et al.
Nature Immunology|July 8, 2008
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationVeit Hornung, Franz Bauernfeind, Annett Halle, et al.
Nature Immunology|February 19, 2026
Author Correction: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationVeit Hornung, Franz Bauernfeind, Annett Halle, et al.
Biochemical and Biophysical Research Communications|July 23, 2011
Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repairSebastian Schlaweck, Sebastian Zimmer, Rafael Struck, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2014
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma modelChristian Bauer, Alexander Sterzik, Franz Bauernfeind, et al.
International Journal of Cancer|May 18, 2010
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinomaCollin Jacobs, Peter Duewell, Klaus Heckelsmiller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 10, 2015
Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicityChristian Bauer, Claudia Hees, Alexander Sterzik, et al.
Cancer Research|October 4, 2015
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progressionDavid Anz, Moritz Rapp, Stephan Eiber, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2011
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot studyChristian Bauer, Marc Dauer, Samira Saraj, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nature Methods|January 8, 2013
iGLuc: a luciferase-based inflammasome and protease activity reporterEva Bartok, Franz Bauernfeind, Maria G Khaminets, et al.
Nature|January 23, 2009
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCVeit Hornung, Andrea Ablasser, Marie Charrel-Dennis, et al.
Nature Immunology|July 8, 2008
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationVeit Hornung, Franz Bauernfeind, Annett Halle, et al.
Nature Immunology|February 19, 2026
Author Correction: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationVeit Hornung, Franz Bauernfeind, Annett Halle, et al.
Biochemical and Biophysical Research Communications|July 23, 2011
Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repairSebastian Schlaweck, Sebastian Zimmer, Rafael Struck, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2014
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma modelChristian Bauer, Alexander Sterzik, Franz Bauernfeind, et al.
International Journal of Cancer|May 18, 2010
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinomaCollin Jacobs, Peter Duewell, Klaus Heckelsmiller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 10, 2015
Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicityChristian Bauer, Claudia Hees, Alexander Sterzik, et al.
Cancer Research|October 4, 2015
Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progressionDavid Anz, Moritz Rapp, Stephan Eiber, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2011
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot studyChristian Bauer, Marc Dauer, Samira Saraj, et al.
Pageof 2